September 16, 2025 11:45 ET | Source: Transgene S.A. Transgene S.A.
2025 Half-year financial information
Attachment
Transgene and NEC Report 100% Three-Year Disease-Free Survival with TG4050 and Publish Phase 1 Results in Nature Communications
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2026
